Betaine Treatment Reverses Fatty Liver and Insulin Resistance in CYP2E1 Transgenic Mice With NAFLD

被引：0

作者：

Nolan, David M.

Kathirvel, Elango

Morgan, Kengathevy

French, Samuel W.

Morgan, Timothy R.

机构：

来源：

GASTROENTEROLOGY | 2010年 / 138卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1838

引用

页码：S800 / S800

页数：1

共 50 条

[31] CYP2E1 activity in patients with alcoholic liver disease [J].

Dilger, K ;

Metzler, J ;

Bode, JC ;

Klotz, U .

JOURNAL OF HEPATOLOGY, 1997, 27 (06) :1009-1014

[32] In vitro metabolism of styrene to styrene oxide in liver and lung of CYP2E1 knockout mice [J].

Carlson, GP .

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2003, 66 (09) :861-869

[33] Betaine for the prevention and treatment of insulin resistance and fatty liver in a high-fat dietary model of insulin resistance in C57BL mice [J].

Kathirvel, Elango ;

Morgan, Kengathevy ;

Malysheva, Olga V. ;

Caudill, Marie A. ;

Morgan, Timothy R. .

FRONTIERS IN NUTRITION, 2024, 11

[34] CYP2E1 is not involved in ethanol-induced failure of fatty grafts after liver transplantation: Studies with knockout mice. [J].

Lehnert, M ;

Conzelmann, LO ;

Zhong, Z ;

Gonzalez, F ;

Bunzendahl, H ;

Thurman, RG .

HEPATOLOGY, 2001, 34 (04) :193A-193A

[35] Stk25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and NAFLD in mice [J].

Mahlapuu, M. ;

Duran, E. N. ;

Aghajan, M. ;

Amrutkar, M. ;

Sutt, S. ;

Cansby, E. ;

Booten, S. ;

Watt, A. ;

Stahlman, M. ;

Stefan, N. ;

Haering, H. -U. ;

Staiger, H. ;

Boren, J. ;

Marschall, H. -U. .

JOURNAL OF HEPATOLOGY, 2018, 68 :S328-S328

[36] Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression [J].

Woodcroft, KJ ;

Hafner, MS ;

Novak, RF .

HEPATOLOGY, 2002, 35 (02) :263-273

[37] Antibiotic furazolidone induces CYP1A but not CYP2E1 subfamily in rat liver [J].

Sasaki, Nobuo ;

Sakai, Noriaki ;

Ikenaka, Yoshinori ;

Kamiya, Tomomi ;

Heewon, Min ;

Sakamotoo, Kentaro Q. ;

Ishizuka, Mayumi ;

Fujita, Shoichi .

JOURNAL OF VETERINARY MEDICAL SCIENCE, 2008, 70 (03) :223-226

[38] EXPRESSION OF CYP2E1 DURING HUMAN FETAL DEVELOPMENT - METHYLATION OF THE CYP2E1 GENE IN HUMAN FETAL AND ADULT LIVER SAMPLES [J].

JONES, SM ;

BOOBIS, AR ;

MOORE, GE ;

STANIER, PM .

BIOCHEMICAL PHARMACOLOGY, 1992, 43 (08) :1876-1879

[39] Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity:: Comparison of wild-type and Cyp2e1(-/-) mice [J].

Wolf, Kristina K. ;

Wood, Sheryl G. ;

Allard, Jenna L. ;

Hunt, Jane A. ;

Gorman, Nadia ;

Walton-Strong, Brooke W. ;

Szakacs, Juliana G. ;

Duan, Su X. ;

Hao, Qin ;

Court, Michael H. ;

von Moltke, Lisa L. ;

Greenblatt, David J. ;

Kostrubsky, Vsevolod ;

Jeffery, Elizabeth H. ;

Wrighton, Steven A. ;

Gonzalez, Frank J. ;

Sinclair, Peter R. ;

Sinclair, Jacqueline F. .

DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) :1223-1231

[40] In vivo inhibition of CYP2E1 fails to reduce pulegone-induced liver injury in mice [J].

Huan, Liwen ;

Zhang, Yahong ;

Liu, Wenwen ;

Lu, Hongyu ;

Zhang, Cai ;

Yin, Runting ;

Ouyang, Zhen ;

Wei, Yuan .

XENOBIOTICA, 2025, 55 (02) :121-130

← 1 2 3 4 5 →